Susceptibility Testing In Neisseria Gonorrhoeae (STING) Study, Assessing the Performance of a New Rapid Test for Gonorrhoea Antibiotic Resistance, in a Cohort of 100 Culture Positive Neisseria Gonorrhoeae Infections

Launched by SPEEDX PTY LTD · Apr 5, 2024

Keywords

ClinConnect Summary

The STING study is researching a new test called InSignia that quickly checks if the bacteria causing gonorrhea are resistant to antibiotics. This is important because knowing which antibiotics will work against the infection can help doctors choose the best treatment for their patients. The study will involve 100 participants who have a confirmed or suspected gonorrhea infection and will look at how well this new test performs with different samples from patients.

To be part of the study, participants need to be 18 years or older and must agree to give their consent to join. However, if someone has taken antibiotics in the last two weeks or is not fluent enough in English to understand the study, they won’t be eligible. Participants can expect to undergo a test that will help improve how we diagnose and treat gonorrhea in the future, and their involvement will contribute to better understanding this important health issue.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Confirmed/suspected NG infection
• • Willingness to give written informed consent as well as to participate in and comply with the study.
• Exclusion Criteria:
• • Currently taking or having taken any antibiotics in the preceding 14 days
• • English fluency below level required to understand study procedures
• • Unwilling or unable to comply with study procedures